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the Caribbean coast of Colombia 
continues to increase, the potential 
for arenavirus-related disease could 
become a public health concern.
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High Incidence of 
Guillain-Barré 
Syndrome in 
Children, 
Bangladesh
To the Editor: Bangladesh has 
achieved remarkable success in its 
drive to eliminate poliomyelitis; 
no case has been reported from 
that country since 2000. Still, the 
nonpolio incidence rate of acute 
ﬂ  accid paralysis (AFP) in Bangladesh 
is 3.25 cases per 100,000 children 
<15 years of age (1). Guillain–
Barré syndrome (GBS), an acute 
polyradiculoneuropathy, is the most 
frequent cause of AFP (2). GBS in 
Bangladesh is frequently preceded 
by an enteric infection caused by 
Campylobacter jejuni ( 3). Frequent 
exposure to enteric pathogens at an 
early age may increase the incidence 
of GBS. We hypothesized that most 
AFP cases in Bangladesh can be 
diagnosed as GBS. Our objective was 
to estimate the crude incidence rate 
of GBS among children <15 years of 
age in Bangladesh.
In collaboration with the World 
Health Organization (WHO), the 
Government of Bangladesh conducts 
active AFP surveillance. AFP is 
deﬁ   ned as acute onset of focal or 
general ﬂ  accid (hypotonic) weakness 
without other obvious cause (e.g., 
trauma) in children <15 years of age. 
Data on the number of reported AFP 
cases in Bangladesh during 2006 and 
2007 were obtained. On the basis 
of clinical and other information 
routinely collected through the 
surveillance system, we deﬁ  ned a GBS 
case as presence of an acute ﬂ  accid 
(hypotonic) paralysis and symmetrical 
weakness (4) in the absence of injury 
or birth trauma.
Bangladesh is divided into 6 
divisions (major administrative 
regions) comprising 64 districts. 
Crude incidence data for GBS were 
calculated per division and per district 
on the basis of the population <15 
years of age reported by WHO and the 
Government of Bangladesh.
In 2006 and 2007, a total of 1,619 
and 1,844 AFP cases, respectively, 
were reported in children <15 years 
of age, of which 608 (37%) and 855 
(46%) cases, respectively, fulﬁ  lled 
the GBS case deﬁ  nition.  The  crude 
incidence rate for GBS in children 
<15 years of age varied from 1.5 to 1.7 
cases per 100,000 population in the 3 
northern divisions (Dhaka, Rajshahi, 
and Sylhet) and from 2.1 to 2.5 per 
100,000 in the 3 southern divisions 
(Khulna, Barisal, and Chittagong) 
(online Appendix Figure, www.cdc.
gov/EID/content/17/7/1317-appF.
htm). Overall, the crude incidence 
rate of GBS in children <15 years of 
age varied from 1.5 to 2.5 cases per 
100,000 population per year in the 6 
divisions of Bangladesh. Incidence 
rates were high (>5.0/100,000) in 
the Meherpur and Barisal districts 
in southern Bangladesh. We found a 
seasonal ﬂ  uctuation in the frequency 
of patients with GBS; the most cases 
occurred in May (n = 159) and the 
lowest in February (n = 84). GBS 
occurred predominantly among boys 
(59%).
Most incidence studies reported 
in the literature originate from 
Europe and North America (5). A 
recent review reported that the best 
estimate of the global incidence of 
GBS in children <15 years of age is 
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0.6 cases per 100,000 population per 
year. (5). Reports on incidence rates 
in developing countries are scarce. 
The crude incidence rate of GBS in 
Bangladesh in children <15 years 
of age reported here appears to be 
2.5× to 4× higher than that reported 
in the literature. A statistically 
signiﬁ   cant proportion of AFP cases 
in Bangladesh appear to be caused by 
GBS. We cannot explain the difference 
in incidence rates of GBS in the 3 
northern divisions and the 3 coastal 
divisions in southern Bangladesh, 
in which rates are higher. However, 
differences in incidence rates between 
northern and southern Bangladesh may 
be explained by difference in climate 
or epidemiology. Further research is 
required to determine why GBS would 
occur more frequently in southern 
Bangladesh. Population-based data 
correlate well with a smaller scale 
hospital-based study in Khulna (6), in 
which GBS was diagnosed in 47% of 
hospitalized AFP case-patients. Our 
recent hospital-based study shows 
that 25% of GBS case-patients in 
Bangladesh are children <15 years 
of age (3). It is important to highlight 
that the present population-based 
analysis is based on a simpliﬁ  ed case 
deﬁ  nition for GBS. All 25 children in 
the hospital study in whom GBS was 
diagnosed on the basis of National 
Institute of Neurological Disorders 
criteria (7) were also detected through 
population-based surveillance and 
fulﬁ   lled the simpliﬁ   ed GBS case 
deﬁ   nition. Future studies, however, 
should include a validation of the case 
deﬁ  nition used here.
The possibility that GBS is 
related to pandemic (H1N1) 2009 and 
the afﬁ   liated vaccination campaign 
has resurfaced recently (8). For 
successful surveillance of excess GBS 
cases after pandemic (H1N1) 2009 
and for postmarketing surveillance of 
the safety of new vaccines in general, 
data on the background incidence of 
GBS are critical. This report indicates 
that the effect of GBS in Bangladesh 
is substantial and suggests that data 
obtained through the ongoing global 
AFP surveillance program can be used 
to obtain crude incidence data on GBS 
worldwide.
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